IHH Annual Report 2024

97 Roles Of the RMC The primary role of the RMC is to assist the Board in overseeing the establishment and implementation of the risk management framework for the Group by Management so that the Group has a sound, effective and robust risk management and internal control framework in place. The RMC also supports the Board in fulfilling its key risk oversight responsibilities in an integrated and strategic manner, providing oversight, direction, and guidance to Management on the Group’s risk management matters. In carrying out its duties and responsibilities, the RMC has the following authorities: • Obtain external professional advice or other relevant advice and invite persons with relevant experience to attend its meetings, if necessary; • Investigate any matter within its Terms of Reference (TOR), ensuring that it has the necessary resources The Risk Management Committee (RMC) was established on 1 July 2018 following the division of the Audit and Risk Management Committee (ARMC) into two distinct committees, namely the Audit Committee and RMC. The ARMC was originally established on 18 April 2012. and full and unrestricted access to information pertaining to the Group and Management. All employees of the Group are required to comply with the RMC’s requests; • Maintain direct communication channels with Senior Management, in order to stay informed of matters affecting the Group; • Appoint an independent party to conduct or to assist in conducting any investigation, with the terms of appointment approved by the RMC; and • Have access to the advice and services of the Company Secretary. Terms of Reference The RMC is governed by a clearly defined and documented TOR. The TOR of the RMC is periodically reviewed and updated as necessary to ensure it remains current and in compliance with applicable regulations and the Group’s policies. The TOR of the RMC was last reviewed and approved by the Board in February 2022. The TOR of the RMC is published on the Company’s website at https://www.ihhhealthcare.com/investors/ corporate-governance. Composition and Meetings The RMC is composed exclusively of Independent Non-Executive Directors. The RMC members come from diverse backgrounds with extensive experience in healthcare, business strategy, risk management, legal, finance, audit and corporate governance. The Board believes that the composition of the RMC provides the appropriate balance in terms of skills, experience, gender and knowledge to ensure the effective functioning of the RMC. During the financial year under review, the RMC met five times. The composition of the RMC and the attendance record of its members for the year under review are as follows: Director Designation Total Meetings Attended in 2024 Jill Margaret Watts (Chairman) Independent Non-Executive Director 5/5 Dato’ Sri Muthanna bin Abdullah (Member) Independent Non-Executive Director 4/5 Chua Bin Hwee (Member) (Appointed on 14 August 2024) Independent Non-Executive Director 2/2 Ong Ai Lin (Member) (Retired on 28 May 2024) Independent Non-Executive Director 3/3 Risk Management Committee Report

RkJQdWJsaXNoZXIy NDgzMzc=